Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.38 AED | 0.00% | +0.42% | -3.64% |
Apr. 30 | Borouge Posts Higher Q1 Attributable Profit; Revenue Down | MT |
Apr. 30 | Borouge plc Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The company is one of the best yield companies with high dividend expectations.
Weaknesses
- The company is in debt and has limited leeway for investment
- With an enterprise value anticipated at 13.37 times the sales for the current fiscal year, the company turns out to be overvalued.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.64% | 19.47B | - | ||
-12.70% | 5.36B | A- | ||
+3.03% | 4.11B | B | ||
+14.27% | 1.54B | B | ||
-5.29% | 1.19B | B- | ||
+23.04% | 987M | - | ||
-18.27% | 635M | - | - | |
-40.32% | 530M | - | ||
-22.14% | 262M | - | - | |
-7.09% | 246M | D- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BOROUGE Stock
- Ratings Borouge plc